0 Комментарии
0 Поделились
66 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Sulfasalazine Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Inflammatory Bowel Disease and Rising Demand for Effective MedicationsThe Sulfasalazine Market is estimated to be valued at US$ 2.01 billion in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Sulfasalazine Market refers to the global market for the drug Sulfasalazine, which is primarily used to treat inflammatory bowel disease such as...0 Комментарии 0 Поделились 1149 Просмотры 0 предпросмотр
- Sulfasalazine Market Poised to Witness High Growth Due to Increasing Geriatric PopulationThe global sulfasalazine market is estimated to be valued at US$ 2.32 Bn in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2024 to 2031. SWOT Analysis Strength: Sulfasalazine is a highly effective treatment for rheumatoid arthritis and inflammatory bowel diseases like ulcerative colitis. It is prescribed generically and is very affordable...0 Комментарии 0 Поделились 917 Просмотры 0 предпросмотр
- Sulfasalazine: A History of Treatment for Inflammatory Bowel DiseaseDiscovery and Mechanism of ActionIt was first synthesized in the 1930s as a combination of sulfapyridine, an antibacterial sulfonamide antibiotic, and 5-aminosalicylic acid (5-ASA). Early clinical trials in the 1940s found that it was effective for treating ulcerative colitis. However, its exact mechanism of action for treating inflammatory bowel disease (IBD) was not fully understood until...0 Комментарии 0 Поделились 317 Просмотры 0 предпросмотр